SPF Eggs Market

Global SPF Eggs Market Size (2024 to 2029)

The global SPF eggs market is forecasted to be worth USD 518.6 million by 2029 from USD 349 million in 2024, registering a CAGR of 8.24% during the forecast period.

Specific pathogen-free (SPF) eggs play a major role in controlling the quality of many vaccines. Also, these are useful for disease diagnosis requiring virus isolation. In biomedical and biotechnology fields, these SPF eggs are highly used for quarantine surveillance. SPF egg use is mandatory in producing the vaccines for veterinary use with the chicken embryo origin. While producing human vaccines, the SPF egg use is limited to four products. In research laboratories, SPF eggs have a significant role.

Avian Adenovirus Group 1&2, Avian Encephalomyelitis, Avian Leucosis, Avian Nephritis, Avian Rhinotracheitis, REO malady, Chicken Anaemia, Egg Drop Syndrome'76, Fowl Pox, Infectious Bronchitis, Infectious Bursal Disease, Infectious Laryngotracheitis, Influenza Virus Type-A, Marek's ailment, and Newcastle ailment among others are particular pathogens for the Specific Pathogen Free (SPF) eggs.

MARKET DRIVERS

The use of SPF eggs in the production of vaccines is majorly propelling the growth of the global SPF Eggs market.

SPF eggs have a unique role in developing vaccines. The use of these products in research activities has positively impacted the results of the vaccines. This has propelled the demand for the SPF eggs market tremendously. Increasing demand to promote quality services in healthcare is gaining traction. Rising prominence for developing vaccines effectively to improve the quality of treatment procedures is a major driving factor for market growth. A growing number of the patient population with various health disorders is ascribed to bolster the demand of the SPF eggs market to the extent. Furthermore, government organizations are greatly supporting these techniques to improve healthcare services, which is likely to boost market growth. In addition, the rising number of infectious diseases and the growing need to develop a vaccine in less time are anticipated to leverage the growth rate of the market. Also, ongoing research and development activities to invent effective drugs or vaccines in favour of the end-users are escalating the market demand. Also, the rising prevalence of meat consumption and the increasing need for SPF eggs from the poultry industry are elevating the growth rate of the SPF eggs market. The emerging application of SPF eggs in various fields presents growth opportunities for market growth.

MARKET RESTRAINTS

Growing complications in in-vitro fertilization with the use of SPF eggs decline the growth rate of the market.

The utilization of SPF eggs in in-vitro fertilization leads to specific difficulties for the research person to handle, which is a degrading factor for the market to grow. High investment costs for research and development activities are slowly hindering the growth rate of the market. The lack of trained people in the research laboratories has additionally impeded the growth for the SPF eggs market. Besides, stringent rules and regulations in approving innovative products are slowly degrading the growth rate of the market.

Impact of COVID-19 on the SPF Eggs Market

COVID-19 is a deadly disease that ruined many lives. World Health Organization (WHO) declared the spread of COVID-19 as a pandemic in March 2020. Since then, all the countries have imposed a lockdown and a ban on flights. SPF egg market shares have doubled during the pandemic as there is a high necessity to invent a vaccine in less time with high accuracy. All the pharmaceuticals and biomedical companies are in a race to find a vaccine to treat novel coronavirus. This attribute has influenced the growth rate of the market positively. Also, there is a huge demand for SPF eggs from the poultry industry to develop a vaccine for veterinary purposes using egg-based. Comprehensive treatment and prevention of the spread of the coronavirus play a major role for researchers in healthcare. Development of a vaccine to contaminate the novel coronavirus was commenced immediately across the world. Therefore, the use of SPF eggs also increased during the COVID-19 pandemic.

REPORT COVERAGE

REGIONAL ANALYSIS

Geographically, the North American SPF Eggs market was the global market leader, with an increasing number of research centers. The rapid adoption of advanced technologies is merely to propel the demand of the market in this region. Besides, the growing demand for the launch of innovative products in healthcare and the rising prominence of quality treatment services are greatly influencing the market’s growth. The US is contributing the highest share of the market. The increasing population and rising demand for meat consumption are likely to fuel the growth rate of the market in this country. Canada is next to the U.S., dominating the market shares with increasing support from private and public organizations through funds.  

Following North America, Europe is holding with the highest share of the market. Constant economic growth and increasing funds from the government to develop an effective vaccine are fuelling the growth rate of the market. In addition, the presence of different key players and quick adoption of the advanced techniques in developing vaccines are merely to boost the growth rate of the SPF eggs market in Europe.

Asia Pacific is projected to grow faster in the coming years with the increasing demand for the production of vaccines using SPF eggs. Rising awareness of the benefits included in these techniques is likely to promote the growth rate of the market in this region. India and China are the leading countries holding the largest shares of the SPF eggs market.

KEY PARTICIPANTS IN THE GLOBAL SPF EGGS MARKET

Companies playing a key role in the global SPF eggs market profiled in this report are Valo BioMedia GmbH, Charles River, Jinan Spafas Poultry Co. Ltd, Couvoir de Cerveloup, ALPES, RM Group, Venkateshwara Hatcheries Pvt Ltd, Razi Vaccine and Serum Research Institute, and Immunetic Lifesciences Private Limited.

On April 13, 2020, Razi Institute, one of the reputed scientific centers in Iran, launched an SPF mouse breeding system that improves its quality. The company is waiting for approvals from the World Health Organization (WHO) and the International Council for Laboratory Animal Sciences (ICLAS).